Active Clinical Trials

Autologous Redirected RNA Meso-CIR T Cells

By April 24, 2017 No Comments


Malignant Pleural Mesothelioma

Estimated Enrollment: 18

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: UPCC 17510

Study First Received: May 17, 2011

Last Updated: October 18, 2016

Estimated Primary Completion Date: July 2015


Primary Outcome Measures:

Adverse Events|Clinical response Rate

Sponsors and Collaborators:

University of Pennsylvania

Website Link:

Leave a Reply

Call Now